Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by MrMugsyon Dec 18, 2020 6:06pm
153 Views
Post# 32145455

RE:RE:RE:RE:Consistent stronger volume

RE:RE:RE:RE:Consistent stronger volume
Investor808TA wrote: Mugsy..you think its insiders? Or Meir sold to big investor?


Meir will get his opportunity to make money - can't imagine him selling at 5 when Goodman would have given him a much better price earlier on.

If it was simply people/intitutional selling, the share price would have taken a hit.

Today's activity was  well controlled by the buyers demand at these prices.  In my opinion, friendly buying going on.  Else we would have seen a red day.  Not the case.

We'll know when the buying report eventually comes out.

This smells of typical Goodman - won't get caught a second time like Meir tried.  Jus my opinion as we try to figure it out.  I would expect a lot of friendly buying at these prices.
<< Previous
Bullboard Posts
Next >>